LambdaVision has recently closed a $7M seed funding round co-led by Seven Seven Six and Aurelia Foundry Fund, with additional support from Seraphim Space, providing runway into 2027. With this funding ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

Dim indoor light and prolonged close focus may be quietly fueling the global rise in nearsightedness.

Blurry vision isn’t always due to screen strain or ageing. Ophthalmologists warn it can signal vitamin deficiencies like A, ...

Paired with external glasses, a tiny chip that is surgically placed under the retina is helping people who are legally blind ...

We’ve been looking at the wrong part of the eye. New research shows the earliest signs of Alzheimer's are hidden at the very edges of the retina.

Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan ...

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.